Measurable residual disease assessment prior to ...
A study on AML/MDS patients post-alloHSCT in CR found MRD status significantly impacts survival outcomes. MRD-negative patients had better OS, DFS, and lower CIR than MRD-positive ones. Combining MFC and molecular-PCR for MRD assessment is crucial due to the impact of inter-method discordance on prognosis.
Reference News
Measurable residual disease assessment prior to ...
A study on AML/MDS patients post-alloHSCT in CR found MRD status significantly impacts survival outcomes. MRD-negative patients had better OS, DFS, and lower CIR than MRD-positive ones. Combining MFC and molecular-PCR for MRD assessment is crucial due to the impact of inter-method discordance on prognosis.